Traditional Chinese medicine composition for treating gynecomastia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for developmental diseases and compositions, which is applied in the field of traditional Chinese medicine compositions for the treatment of abnormal gynecomastia, can solve the problems of treating the symptoms but not the root causes, side effects, etc., and achieves the effects of simple preparation, wide source of medicines, and remarkable and reliable curative effect
Inactive Publication Date: 2016-06-01
孙茂志
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, although the drugs for treating gynecomastia have certain curative effects, the...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0012] A traditional Chinese medicine composition for treating gynecomastia, wherein the raw materials and weight ratio of the medicine are as follows: 20g Scutellaria barbata, 10g Toosendan, 15g Cynomorium, 20g Arrowhead, 10g Sea Dragon, 15g sea clam shell, 15g peppermint , Chuanxiong 10g, Acanthopanax 20g, Chunjian 10g, Dandelion 15g, Fritillaria 15g, Shayuanzi 15g, Cyperus cyperi 10g, Corrugated seeds 15g, Cuscuta 15g, Cat's claw 10g, Nocturnal vine 15g, Safflower 15g, Turmeric 15g, Polygonum multiflorum 10g, Polygonum cuspidatum 15g, Licorice 10g.
Embodiment 2
[0014] A traditional Chinese medicine composition for treating gynecomastia, wherein the raw materials and the weight ratio of the medicine are: 15g barbatae, 20g Chuanzilian, 10g Cynomorium, 25g Shanzigu, 12g sea dragon, 20g sea clam shell, 5g peppermint , Chuanxiong 15g, Acanthopanax 10g, Chunjian 20g, Dandelion 15g, Fritillaria 25g, Shayuanzi 10g, Cyperus cyperus 20g, Corrugated seeds 5g, Cuscuta 25g, Cat's claw 12g, Nocturnal vine 20g, Safflower 5g, Turmeric 25g, Polygonum multiflorum 12g, Polygonum cuspidatum 20g, Licorice 5g.
Embodiment 3
[0016] A traditional Chinese medicine composition for treating gynecomastia, wherein the raw materials and weight ratio of the medicine are as follows: 25g Scutellaria barbata, 5g Toosendan, 20g Cynomorium, 15g Arrowhead, 5g Sea Dragon, 25g sea clam shell, 10g Peppermint , Chuanxiong 20g, Acanthopanax 15g, Chunjian 5g, Dandelion 10g, Fritillaria 20g, Shayuanzi 5g, Cyperus cyperi 15g, Corrugated seed 10g, Cuscuta 20g, Cat's Claw 5g, Nocturnal vine 25g, Safflower 10g, Turmeric 20g, Polygonum multiflorum 5g, Polygonum cuspidatum 25g, Licorice 12g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition for treating gynecomastia. The traditional Chinese medicine composition comprises, by weight, 10-30 parts of scutellariae barbatae, 5-20 parts of melia toosendan, 5-25 parts of cynomorium songaricum, 10-30 parts of rhizoma pleionis, 5-20 parts of medical pipefish, 5-25 parts of concha meretricis seu cyclinae, 5-25 parts of mentha haplocalyx, 5-20 parts of rhizoma chuanxiong, 10-30 parts of radix acanthopanacis senticosi, 5-20 parts of botrypus virginianus, 5-25 parts of taraxacum mongolicum, 5-25 parts of rhizoma bolbostemmae, 5-25 parts of semen astragali complanati, 5-20 parts of rhizoma cyperi, 5-25 parts of concha arcae, 5-25 parts of semen cuscutae, 5-20 parts of radix ranunculi ternati, 5-25 parts of caulis polygoni multiflora, 5-25 parts of carthamus tinctorious, 5-25 parts of radix curcuma, 5-20 parts of prepared polygonum multiflorum, 5-25 parts of polygonum cuspidatum and 5-15 parts of radix glycyrrhizae. The traditional Chinese medicine composition has effects of tonifying the liver and kidney, soothing the liver and expelling heat, reducing phlegm and softening hard mass, eliminating stagnation and diminishing swelling, promoting qi circulation and relieving depression, and clearing the channels and collaterals and relieving pain and is evident and reliable in curative effect on the gynecomastia.
Description
technical field [0001] The invention relates to a medicinal preparation of an undetermined structure of a traditional herbal medicine, in particular to a traditional Chinese medicine composition for treating abnormal gynecomastia. Background technique [0002] Gynecomastia is also known as "gynecomastia" or "gynecomastia". Refers to male breast hypertrophy on one or both sides, with disc-shaped nodules touching under the areola, often with fibrous tissue and fat tissue hyperplasia, and pain or tenderness. Sometimes it can be accompanied by breast distending pain, which is a common clinical male breast disease. It occurs in men of almost any age. At present, although the medicines for treating gynecomastia have certain curative effects, they have the disadvantages of treating the symptoms but not the root cause and certain side effects. [0003] Chinese medicine believes that gynecomastia is caused by congenital deficiency of kidney qi, or acquired deficiency of liver and ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more